Cargando…

Molecular targets for the rational design of drugs to inhibit SARS coronavirus

Despite years of research, the precise determinants of coronavirus replication and pathogenesis remain unidentified. What is known of the pathogenesis of the severe acute respiratory syndrome coronavirus (SARS-CoV) is limited, but clinical observations suggest that both viral-induced cytotoxicity an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brockway, Sarah M., Denison, Mark R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105069/ https://www.ncbi.nlm.nih.gov/pubmed/32288772 http://dx.doi.org/10.1016/j.ddmec.2004.08.016

Ejemplares similares

Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication
por: Brockway, Sarah M., et al.
Publicado: (2005)

Rational drug design
por: Truhlar, Donald, et al.
Publicado: (1999)

TRPV1: A Target for Rational Drug Design
por: Carnevale, Vincenzo, et al.
Publicado: (2016)

Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2021)

Rational Design of “Heat Seeking” Drug Loaded Polypeptide Nanoparticles That Thermally Target Solid Tumors
por: McDaniel, Jonathan R., et al.
Publicado: (2014)

Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design
por: Xu, Xiang, et al.
Publicado: (2003)

SARS coronavirus replicase proteins in pathogenesis
por: Graham, Rachel L., et al.
Publicado: (2008)

Rational design of oral drugs targeting mucosa delivery with gut organoid platforms
por: Tong, Tianjian, et al.
Publicado: (2023)

Effects of Mutagenesis of Murine Hepatitis Virus NSP1 and NSP14 on Replication in Culture
por: Eckerle, Lance D., et al.
Publicado: (2006)

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy
por: Chiang, Austin W. T., et al.
Publicado: (2021)

Computational Methods Applied to Rational Drug Design
por: Ramírez, David
Publicado: (2016)

Rational Chemical Design of Molecular Glue Degraders
por: Toriki, Ethan S., et al.
Publicado: (2023)

Rationality over fashion and hype in drug design
por: Medina-Franco, José L., et al.
Publicado: (2021)

Rationally Designed Chimeric Antibodies for COVID-19 and Future Coronavirus Variants
por: Hsueh, Ching-chung, et al.
Publicado: (2021)

Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug Design
por: Leighow, Scott M., et al.
Publicado: (2020)

Rational Approaches to Improving Selectivity in Drug Design
por: Huggins, David J., et al.
Publicado: (2012)

GPCR Conformations: Implications for Rational Drug Design
por: Parrill, Abby L., et al.
Publicado: (2010)

Rationally Designed DNA Nanostructures for Drug Delivery
por: Xu, Fan, et al.
Publicado: (2020)

Inhibition of synucleinopathic seeding by rationally designed inhibitors
por: Sangwan, Smriti, et al.
Publicado: (2020)

Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?
por: Dodaro, Andrea, et al.
Publicado: (2023)

Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein
por: Dharra, Renu, et al.
Publicado: (2017)

Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
por: Nunes, José E. S., et al.
Publicado: (2020)

Rational peptide design for inhibition of the KIX–MLL interaction
por: Sato, Nao, et al.
Publicado: (2023)

Correction to “Rational Chemical Design of Molecular Glue Degraders”
por: Toriki, Ethan S., et al.
Publicado: (2023)

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
por: Báez-Santos, Yahira M., et al.
Publicado: (2015)

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Du, Lanying, et al.
Publicado: (2016)

Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes
por: Li, Minchao, et al.
Publicado: (2021)

The NSP2 Proteins of Mouse Hepatitis Virus and Sars Coronavirus are Dispensable for Viral Replication
por: Graham, Rachel L., et al.
Publicado: (2006)

Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics
por: Fu, Zhiqiang, et al.
Publicado: (2022)

Rational design of non-resistant targeted cancer therapies
por: Martínez-Jiménez, Francisco, et al.
Publicado: (2017)

On the Rational Drug Design for Hypertension through NMR Spectroscopy
por: Chontzopoulou, Eleni, et al.
Publicado: (2020)

Rational design of yolk–shell nanostructures for drug delivery
por: Mohammadi Ziarani, Ghodsi, et al.
Publicado: (2020)

Editorial: Rational drug design of metal complexes for cancer therapy
por: Morais, Tânia S., et al.
Publicado: (2022)

Coronavirus Non-Structural Protein 1 Is a Major Pathogenicity Factor: Implications for the Rational Design of Coronavirus Vaccines
por: Züst, Roland, et al.
Publicado: (2007)

Sars Coronavirus Accessory ORFs Encode Luxury Functions
por: Frieman, Matthew B., et al.
Publicado: (2006)

Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae
por: Ma, Zhiqian, et al.
Publicado: (2020)

Rational, computer-aided design of multi-target ligands
por: Achenbach, J, et al.
Publicado: (2011)

Rational designing of glyco-nanovehicles to target cellular heterogeneity
por: Jain, Prashant, et al.
Publicado: (2021)

Computational Approaches to the Rational Design of Tubulin-Targeting Agents
por: Pérez-Peña, Helena, et al.
Publicado: (2023)

Rational design of alcoholic fermentation targeting extracellular carbon
por: Watanabe, Daisuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jaa7chb3tb09pgahqjiii9g2n7